← Open Payments lookup

LAURA GARZA: Open Payments

NPI 1811351133 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,546 in 85 payments from 19 companies in 2025. Trend: 2023 $2,072 · 2024 $3,047 · 2025 $2,546

Food & beverage: $2,285Travel & lodging: $261
CompanyPaymentsAmount
Boston Scientific Corporation7$532
Novartis Pharmaceuticals Corporation30$375
AstraZeneca Pharmaceuticals LP6$308
Actelion Pharmaceuticals US, Inc.9$264
Boehringer Ingelheim Pharmaceuticals, Inc.4$156
E.R. Squibb & Sons, L.L.C.8$155
ABIOMED1$150
Novo Nordisk Inc2$144
Bayer Healthcare Pharmaceuticals Inc.2$141
Amgen Inc.4$87

Products named: WATCHMAN Access System, LEQVIO, FARXIGA, JARDIANCE, OPSYNVI, Kerendia, CAMZYOS, Ozempic.

Industry payments across TX — which companies pay providers there.